Grimes & Company’s Argan AGX Stock Holding History

Grimes & Company’s Portfolio AGX Stock Details AGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Hold	504	–	–	0.01%	337
2026 Q1	$274K	Buy	+504	New	+$206K	0.01%	370

Other funds holding AGX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LPC

Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return

Grimes & Company's AGX Position: Q2 2026 in Review

Grimes & Company held its Argan (AGX) position steady in Q2 2026 at 504 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #337.

Grimes & Company first reported a position in AGX in Q1 2026 and has held it in 2 quarters since. 562 funds tracked by Wall St. Rank hold AGX as of Q2 2026.

Grimes & Company held 504 shares of Argan worth $402K as of Q2 2026.
Grimes & Company left its Argan share count unchanged in Q2 2026.
Argan made up 0.01% of Grimes & Company's portfolio in Q2 2026, its #337 holding.
Grimes & Company first reported a position in Argan in Q1 2026 and has held it in 2 quarters since.
562 funds tracked by Wall St. Rank held Argan as of Q2 2026.

Based on Grimes & Company's 13F filing for Q2 2026, filed 17 Jul 2026.